Gastrointestinal Cancers
At City of Hope, your care is in the hands of world experts in gastrointestinal (GI) cancers, which include colorectal cancer, stomach cancer and other diseases that affect the digestive system. Our team provides comprehensive, multidisciplinary care and access to the latest in leading-edge treatments for early- and late-stage GI cancer, including robotic and minimally invasive surgery and precision medicine.
City of Hope’s approach to treating gastrointestinal cancers starts with a coordinated, multidisciplinary care team whose primary goals are helping you live a long, healthy life free from cancer.
Clinical trials — research studies that involve volunteer patients — are a crucial component to developing new, more effective gastrointestinal cancer treatments that save lives.
When you come to City of Hope, you have access to a strong network of support services and staff to help you and your family along your gastrointestinal cancer journey.
At City of Hope, we provide our patients with access to breakthrough cancer treatments in an environment centered on compassionate care. That’s why we have been recognized as one of the country's leading cancer research and treatment centers by U.S. News & World Report for more than a decade. City of Hope is also designated as a comprehensive cancer center, the National Cancer Institute’s highest distinction. We serve patients at our main campus in Duarte, northeast of Los Angeles, and at our other clinical locations across Southern California.
Our team works together to ensure you get the best gastrointestinal cancer treatments and the best survival outcomes using:
- Minimally invasive, robotically assisted surgical techniques to remove tumors with less discomfort, reduced risk of complications and shorter recovery times.
- Leading-edge treatment options, including highly precise radiation therapy to treat tumors with minimal exposure to surrounding normal tissue.
- Targeted drugs and drug combinations that treat advanced GI cancers with greater effectiveness and fewer side effects than traditional chemotherapy.
- A wide range of GI cancer clinical trials, giving patients access to the newest cancer treatments and tests not readily available elsewhere.
- Supportive care services to help patients and their loved ones with wellness and palliative care issues that may arise during and after GI cancer treatment.
City of Hope is one of the few facilities designated a comprehensive cancer center by the National Cancer Institute.
Our developments in the areas of breakthrough cancer drugs, bone marrow transplants and CAR T cell therapy are recognized internationally.
Our leadership in research and innovation continually enhances our ability to provide novel and differentiated approaches to cancer care.
Mustafa Raoof, M.D., M.S., is a surgical oncologist and an assistant professor in the Department of Surgery and in the Department of Cancer Genetics and Epigenetics.
Stephen M. Sentovich, M.D., M.B.A., is a colorectal surgeon and a clinical professor in the Division of Colorectal Surgery, Department of Surgery.
Vijay Trisal, M.D., the Dr. Norman & Melinda Payson Professor in Medicine, is the system chief clinical officer responsible for setting the vision and direction for systemwide quality, patient safety, and developing guidelines for clinical pathways and protocols.
Vincent Chung, M.D., is a medical oncologist specializing in pancreatic cancer and gastrointestinal cancers.
Marwan G. Fakih, M.D., is a medical oncologist specializing in gastrointestinal cancers.
Daneng Li, M.D., is a medical oncologist specializing in geriatric oncology and treating gastrointestinal cancers.
Dupinder Singh, M.D., is a gastroenterologist-hepatologist in the Department of Medicine at City of Hope.